bay x 1005 has been researched along with mocetinostat in 4 studies
| Studies (bay x 1005) | Trials (bay x 1005) | Recent Studies (post-2010) (bay x 1005) | Studies (mocetinostat) | Trials (mocetinostat) | Recent Studies (post-2010) (mocetinostat) |
|---|---|---|---|---|---|
| 58 | 6 | 8 | 21,735 | 390 | 8,606 |
| Protein | Taxonomy | bay x 1005 (IC50) | mocetinostat (IC50) |
|---|---|---|---|
| Histone deacetylase 3 | Homo sapiens (human) | 0.7851 | |
| Nuclear receptor corepressor 1 | Homo sapiens (human) | 0.022 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.57 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.102 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.102 | |
| Histone deacetylase 4 | Homo sapiens (human) | 0.5717 | |
| Histone deacetylase 1 | Homo sapiens (human) | 0.3433 | |
| Histone deacetylase 7 | Homo sapiens (human) | 0.6725 | |
| Histone deacetylase 2 | Homo sapiens (human) | 0.3537 | |
| Histone deacetylase 11 | Homo sapiens (human) | 0.6386 | |
| Histone deacetylase 8 | Homo sapiens (human) | 0.6725 | |
| Histone deacetylase 6 | Homo sapiens (human) | 0.5717 | |
| Histone deacetylase 5 | Homo sapiens (human) | 0.6725 | |
| Nuclear receptor corepressor 2 | Homo sapiens (human) | 0.045 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Berti, F; Buccellati, C; Folco, GC; Maclouf, J; Molta, C; Muller-Peddinghaus, R; Rossoni, G; Sala, A; Testa, T | 1 |
| Berti, F; Buccellati, C; Folco, G; Maclouf, J; Rossoni, G; Sala, A | 1 |
| Adalsteinsdottir, AE; Agnarsson, U; Andersen, K; Andresdottir, M; Arnar, DO; Bjornsdottir, H; Einarsson, A; Gottskalksson, G; Gudbjartsson, D; Gudmundsdottir, H; Gudmundsson, K; Gulcher, J; Gurney, M; Hakonarson, H; Hardarson, T; Helgadottir, A; Jonsson, A; Kong, A; Kristinsson, A; Kristjansson, K; Manolescu, A; Sigurdsson, A; Stefansson, K; Thorgeirsson, G; Thorvaldsson, S; Topol, EJ; Zink, F | 1 |
1 trial(s) available for bay x 1005 and mocetinostat
| Article | Year |
|---|---|
Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial.
Topics: 5-Lipoxygenase-Activating Proteins; Aged; Biomarkers; Carrier Proteins; Coronary Artery Disease; Cross-Over Studies; Epoxide Hydrolases; Female; Humans; Leukotriene B4; Leukotriene E4; Lipoxygenase Inhibitors; Male; Membrane Proteins; Middle Aged; Myocardial Infarction; Peroxidase; Polymorphism, Single Nucleotide; Prospective Studies; Quinolines; Risk Factors | 2005 |
3 other study(ies) available for bay x 1005 and mocetinostat
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Myocardial protection by the leukotriene synthesis inhibitor BAY X1005: importance of transcellular biosynthesis of cysteinyl-leukotrienes.
Topics: Animals; Arachidonate 5-Lipoxygenase; Calcimycin; Coronary Vessels; Creatine Kinase; Cysteine; Electrocardiography; Endothelium, Vascular; Enzyme Activation; Heart; Heart Diseases; Humans; In Vitro Techniques; L-Lactate Dehydrogenase; Leukotrienes; Lipoxygenase Inhibitors; Male; Myocardial Ischemia; Myocardium; Neutrophils; Peroxidase; Quinolines; Rabbits | 1996 |
Leukotrienes in cardiovascular diseases.
Topics: Animals; Cardiovascular Diseases; Electrocardiography; Heart; In Vitro Techniques; Leukotrienes; Lipoxygenase Inhibitors; Male; Myocardium; Peroxidase; Quinolines; Rabbits; Random Allocation | 2000 |